NEWS
Stellate Therapeutics Strengthens Senior Management Team
Press Release
David Immke joins as Chief Scientific Officer and Jonathan Weiss as
Director of Business Development
Read more
Stellate Therapeutics Appoints Sophie Durand as Chief Executive Officer and Announces Capital Raise
Press Release
- Sophie Durand appointed Chief Executive Officer to guide Stellate Therapeutics towards clinical trials
- Investment from eureKARE to bring long-term expertise, financial and operational support
Read more- Investment from eureKARE to bring long-term expertise, financial and operational support
